BECTON DICKINSON & CO (NYSE:BDX) filed a Form 8-K with the Securities and Exchange Commission on January 30, 2026, disclosing a material event.
BECTON DICKINSON & CO's stock currently trades at $203.48 with a market capitalization of $57.4B. The Healthcare company's stock moved following the disclosure.


